Follow
Marc Hennequart
Marc Hennequart
Ludwig Cancer Research
Verified email at bru.licr.org
Title
Cited by
Cited by
Year
Serine synthesis pathway inhibition cooperates with dietary serine and glycine limitation for cancer therapy
M Tajan, M Hennequart, EC Cheung, F Zani, AK Hock, N Legrave, ...
Nature communications 12 (1), 366, 2021
2232021
Constitutive IDO1 expression in human tumors is driven by cyclooxygenase-2 and mediates intrinsic immune resistance
M Hennequart, L Pilotte, S Cane, D Hoffmann, V Stroobant, ED Plaen, ...
Cancer immunology research 5 (8), 695-709, 2017
1662017
Cancer-specific loss of p53 leads to a modulation of myeloid and T cell responses
J Blagih, F Zani, P Chakravarty, M Hennequart, S Pilley, S Hobor, ...
Cell reports 30 (2), 481-496. e6, 2020
1602020
Single-cell resolved imaging reveals intra-tumor heterogeneity in glycolysis, transitions between metabolic states, and their regulatory mechanisms
H Kondo, CDH Ratcliffe, S Hooper, J Ellis, JI MacRae, M Hennequart, ...
Cell reports 34 (7), 2021
982021
The dietary sweetener sucralose is a negative modulator of T cell-mediated responses
F Zani, J Blagih, T Gruber, MD Buck, N Jones, M Hennequart, CL Newell, ...
Nature 615 (7953), 705-711, 2023
532023
microRNA-155, induced by interleukin-1ss, represses the expression of microphthalmia-associated transcription factor (MITF-M) in melanoma cells
N Arts, S Cané, M Hennequart, J Lamy, G Bommer, B Van den Eynde, ...
PLoS One 10 (4), e0122517, 2015
472015
The impact of physiological metabolite levels on serine uptake, synthesis and utilization in cancer cells
M Hennequart, CF Labuschagne, M Tajan, SE Pilley, EC Cheung, ...
Nature Communications 12 (1), 6176, 2021
362021
Constitutive IDO1 expression in human tumors is driven by cyclooxygenase-2 and mediates intrinsic immune resistance. Cancer Immunol Res.(2017) 5: 695–709. doi: 10.1158/2326-6066
M Hennequart, L Pilotte, S Cane, D Hoffmann, V Stroobant, E Plaen, ...
CIR-16-0400, 0
33
ALDH1L2 regulation of formate, formyl-methionine, and ROS controls cancer cell migration and metastasis
M Hennequart, SE Pilley, CF Labuschagne, J Coomes, L Mervant, ...
Cell Reports 42 (6), 2023
232023
Tissue nutrient environments and their effect on regulatory T cell biology
J Blagih, M Hennequart, F Zani
Frontiers in Immunology 12, 637960, 2021
182021
Cycling back to folate metabolism in cancer
Y Lee, KH Vousden, M Hennequart
Nature cancer, 1-15, 2024
72024
Loss of attachment promotes proline accumulation and excretion in cancer cells
SE Pilley, M Hennequart, A Vandekeere, J Blagih, NM Legrave, SM Fendt, ...
Science Advances 9 (36), eadh2023, 2023
72023
Dietní sladidlo sukralóza je negativním modulátorem reakcí zprostředkovaných T-lymfocyty
F Zani, J Blagih, T Gruber, MD Buck, N Jones, M Hennequart, CL Newell, ...
Listy Cukrovarnické a Reparské 140 (11), 395-395, 2024
2024
Cycling back to folate metabolism in cancer
L Younghwan, KH Vousden, M Hennequart
Nature Cancer 5 (5), 701-715, 2024
2024
Deciphering the pathways that lead to IDO1 constitutive expression in human cancer cells
M Hennequart
UCL-Université Catholique de Louvain, 2017
2017
The system can't perform the operation now. Try again later.
Articles 1–15